BioLineRx (BLRX) Receivables - Other (2023 - 2025)
Historic Receivables - Other for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $699000.0.
- BioLineRx's Receivables - Other rose 9971.43% to $699000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $699000.0, marking a year-over-year increase of 9971.43%. This contributed to the annual value of $1.5 million for FY2024, which is 7807.23% up from last year.
- BioLineRx's Receivables - Other amounted to $699000.0 in Q3 2025, which was up 9971.43% from $203000.0 recorded in Q2 2025.
- In the past 5 years, BioLineRx's Receivables - Other ranged from a high of $1.5 million in Q4 2024 and a low of $128000.0 during Q2 2023
- Its 3-year average for Receivables - Other is $538181.8, with a median of $452000.0 in 2025.
- In the last 5 years, BioLineRx's Receivables - Other surged by 41250.0% in 2024 and then plummeted by 6905.49% in 2025.
- Quarter analysis of 3 years shows BioLineRx's Receivables - Other stood at $830000.0 in 2023, then surged by 78.07% to $1.5 million in 2024, then tumbled by 52.71% to $699000.0 in 2025.
- Its last three reported values are $699000.0 in Q3 2025, $203000.0 for Q2 2025, and $452000.0 during Q1 2025.